Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common stock, par value $0.001 per share
-
Shares outstanding
-
148M
-
Number of holders
-
48
-
Total 13F shares, excl. options
-
17.3M
-
Shares change
-
+481K
-
Total reported value, excl. options
-
$339M
-
Value change
-
+$9.49M
-
Put/Call ratio
-
0
-
Number of buys
-
16
-
Number of sells
-
-22
-
Price
-
$19.59
Significant Holders of 89bio, Inc. - Common stock, par value $0.001 per share (ETNB) as of Q3 2021
53 filings reported holding ETNB - 89bio, Inc. - Common stock, par value $0.001 per share as of Q3 2021.
89bio, Inc. - Common stock, par value $0.001 per share (ETNB) has 48 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17.3M shares
of 148M outstanding shares and own 11.68% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (4.97M shares), ORBIMED ADVISORS LLC (3.73M shares), WELLINGTON MANAGEMENT GROUP LLP (1.7M shares), EVENTIDE ASSET MANAGEMENT, LLC (1.14M shares), FRANKLIN RESOURCES INC (806K shares), BlackRock Inc. (732K shares), FMR LLC (651K shares), VANGUARD GROUP INC (607K shares), Candriam Luxembourg S.C.A. (488K shares), and CITADEL ADVISORS LLC (290K shares).
This table shows the top 48 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.